Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00651625 · ClinicalTrials.gov registry record · NA
Reciprocating Medical Devices - a Study of a New Safety Device
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 437
- Enrollment target
NCT00651625 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 437 participants.
The verdict
NCT00651625, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 437 participants
- Enrollment target
Study Summary
The study design is a randomized study to directly compare the performance and the outcome of syringe and needle procedures with a standard syringe or the new reciprocating procedure device (RDP), which is a type of safety syringe. Over a 5 year period, 820 subjects who require and assent to a syringe and needle procedure for their usual and customary care will be randomized to either a conventional syringe or the RPD with one arm with and without ultrasound guidance. The RPD is designed to be safer, faster, less painful, and more effective for the patient, and the mechanics of the RPD are intended to provide the physician with better needle control, resulting in less needle trauma to patient tissues, and thus, reduced bleeding and pain for the patient. This clinical trial will address whether the RPD is indeed superior to the conventional syringe for shots, injections, and needle procedures, and whether it is a safer, less painful syringe.
Interventions
- DEVICE Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001
- DEVICE conventional syringe - BD Ref 309604
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 437 participants |
| Start Date | 2004-11 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00651625
The ClinicalTrials.gov registry entry for NCT00651625 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 437 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001 is the first listed.
NCT00651625 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00651625 about?
NCT00651625 is a clinical study titled "Reciprocating Medical Devices - a Study of a New Safety Device". The study design is a randomized study to directly compare the performance and the outcome of syringe and needle procedures with a standard syringe or the new reciprocating procedure device (RDP), which is a type of safety syringe. Over a 5 year period, 820 subjects who require and assent to a syrin...
What is the current status of trial NCT00651625?
This trial is currently completed. It is a NA study. The enrollment target is 437 participants. The study started on 2004-11. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00651625?
The interventions under investigation include: Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001 (DEVICE), conventional syringe - BD Ref 309604 (DEVICE).
Who is sponsoring clinical trial NCT00651625?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.